logo
Lead, arsenic found in popular rice brands: Study

Lead, arsenic found in popular rice brands: Study

Yahoo2 days ago

(NewsNation) — Popular rice brands across the United States might contain highly toxic metals, one study has found.
A study conducted by Healthy Babies, Bright Future found that out of 145 rice samples nationwide, 100% of them contained arsenic. According to the organization, more than one in four exceeded the FDA's action level for infant cereal.
How to keep your dogs safe during summer heat
'No such limit exists for rice itself — the bags and boxes of rice served at family meals — despite it being widely consumed by infants and toddlers,' the report stated. 'Additionally, cadmium was found in all but one sample, with some showing elevated levels.'
This would mean that any parents who are making baby food at home that includes homemade rice cereal could risk exposing their children to unsafe levels of arsenic.
Overall, the report found four toxic metals in these rice products: Arsenic, cadmium, lead and mercury.
HBBF reported that these chemicals can lead to cancer, IQ loss and other health effects. The World Health Organization has said that long-term exposure to arsenic that is in our food and water can cause skin lesions and cancer.
Breast cancer vaccine moving to critical phase
The reports found arsenic at the highest levels, with cadmium following behind. In a rice that was seasoned with saffron, tests allegedly showed lead levels that were way higher than in other samples. Brown rice that was grown in the Southeast or labeled as 'grown in the USA' had the highest average levels of these toxic metals, according to the study.
The tests also found that white rice grown in the Southeast had, on average, a higher level of these heavy metals (particularly arsenic) than rice grown in California. Thai jasmine rice and Indian basmati rice overall contained lower levels of these heavy metals than other rice varieties.
Can you lower blood pressure with dark chocolate and tea?
However, basmati rice from India (and arborio rice from Italy) showed the highest average levels of cadmium, according to the test results.
HBBF's study tested 10 different forms of grain and over 100 brands from stores in 20 metropolitan areas. Some of those areas included Seattle, New York, Miami and Los Angeles.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Asia-Pacific Transdermal Skin Patches Market Outlook 2025-2033: Trends for Pain Relief, Smoking Reduction & Cessation Aid, Overactive Bladder, Hormonal Therapy, and Other Applications
Asia-Pacific Transdermal Skin Patches Market Outlook 2025-2033: Trends for Pain Relief, Smoking Reduction & Cessation Aid, Overactive Bladder, Hormonal Therapy, and Other Applications

Yahoo

time3 hours ago

  • Yahoo

Asia-Pacific Transdermal Skin Patches Market Outlook 2025-2033: Trends for Pain Relief, Smoking Reduction & Cessation Aid, Overactive Bladder, Hormonal Therapy, and Other Applications

Innovations in microneedle and smart patch technologies are boosting efficacy and compliance, while government healthcare initiatives enhance access. Major players include Teva Pharmaceutical, 3M, and Johnson & Johnson. Growth is notably strong in China, India, and Japan due to demographic and health trends. Asia-Pacific Transdermal Skin Patches Market Dublin, June 05, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Transdermal Skin Patches Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to Asia-Pacific Transdermal Skin Patches Market is expected to reach US$ 3.96 billion by 2033 from US$ 2.76 billion in 2024, with a CAGR of 4.10% from 2025 to 2033. Increasing prevalence of chronic diseases, aging population, requirement for pain-free drug delivery, technological innovation, growth in healthcare infrastructure, and rising awareness of self-administered therapies that ensure convenience and improved patient compliance are the key drivers of the transdermal skin patches market in Asia-Pacific. Several significant factors are behind the consistent rise of the transdermal skin patch market in Asia-Pacific. The increasing prevalence of chronic conditions such as diabetes, hypertension, and cardiovascular disease is a key driver, since it increases the need for safe, non-invasive drug delivery systems. Increased demand for user-friendly and convenient pharmaceutical solutions is also being driven by the ageing population in the region, most notably in countries such as China and Japan. Efficiency in drug delivery and compliance among patients are being enhanced by advances in technology in the form of smart patches and microneedle technology. In addition, the application of transdermal therapies in the region is being encouraged and access enhanced by government healthcare initiatives as well as increases in healthcare infrastructure. Growth Drivers for the Asia-Pacific Transdermal Skin Patches MarketRising prevalence of respiratory disease The Asian Pacific market for transdermal skin patches is growing largely because of the rising prevalence of chronic diseases. Owing to sedentary lifestyles, environmental influences, and aging populations, chronic conditions such as diabetes, cardiovascular diseases, COPD, and cancer are on the rise. The incidence of chronic obstructive pulmonary disease (COPD) in Indian non-smokers, for instance, ranged from 1.6% to 26.6%, a meta-analysis study published in the Reviews on Environmental Health journal in November 2023 revealed. Also, India detects over 1.39 million new cancer cases every year, the Kidwai Memorial Institute of Oncology says. Long-term medication is often required for most diseases, and transdermal patches offer a steady, non-invasive, and effective route of drug delivery that enhances patient compliance. Demand for effective and convenient treatment options, like transdermal patches, is expected to grow tremendously across the region as the incidence of chronic diseases rises. Technological Advancements The Asia-Pacific market for transdermal skin patches is growing with a swift pace due to technology advancements that raise patient comfort, therapeutic efficacy, and medication administration effectiveness. Transdermally treatable disorders have widened as a result of innovations such as microneedle patches, sensor-embedded smart patches, and better adhesives. These technologies enhance patient compliance, especially among the elderly and the chronically ill, through the delivery of controlled, sustained, and painless medication. Teikoku Seiyaku Co. Ltd. and Kowa Company Ltd.'s April 2023 marketing in Japan of ALLYDONE Patches 27.5 mg and 55 mg for the treatment of dementia caused by Alzheimer's disease is a good case in point. This launch highlights how innovative patch technologies can be employed to treat neurologic diseases. These technological innovations are expected to greatly boost the adoption of transdermal patches across the Asia-Pacific market as research and development proceed. Ageing Population The aging population of the Asia-Pacific region is one of the key drivers of the market for transdermal skin patches. The demand for non-invasive, easy-to-use medicine delivery methods is increasing as the elderly population grows, especially in countries such as China and Japan. China's National Bureau of Statistics announced in January 2022 that the nation's population would be around 1.412 billion in 2021 and is likely to increase to 1.43 billion by the year 2026. Due to their ease of use, sustained drug delivery, and minor side effects, transdermal patches are a preferred option for this aging group, which is often required to take long-term medication for ongoing diseases. The demand for transdermal patches in the region is being fueled by the ability to administer medicine oneself without constant hospital visits, which fits the demands of an aging population. The demand for these advanced distribution systems is expected to evolve further as the number of elderly individuals increases. Challenges in the Asia-Pacific Transdermal Skin Patches MarketLimited Drug Permeability One major obstacle facing the Asia-Pacific transdermal skin patch business is limited medication permeability. The kinds of pharmaceuticals that can be administered via patches are limited by the ineffectiveness of certain drugs un penetrating the epidermal barrier. This restriction lessens the transdermal patches' adaptability and keeps them from being applied to a wider variety of conditions. Skin penetration technologies are being improved by researchers, but this problem will prevent the market from expanding until these developments are widely adopted. Skin Irritation and Sensitivity Significant obstacles in the Asia-Pacific transdermal skin patch industry are skin sensitivity and irritation. Patients may stop wearing the patches regularly if they experience skin problems including rashes, redness, or allergic reactions after using them for an extended period of time. This may limit the market's potential and lower patient compliance. Manufacturers are working to address this by creating hypoallergenic, skin-friendly materials and advancing patch adhesive methods to reduce irritation and improve user comfort, but these issues continue to exist. Key Attributes Report Attribute Details No. of Pages 200 Forecast Period 2024-2033 Estimated Market Value (USD) in 2024 $2.76 Billion Forecasted Market Value (USD) by 2033 $3.96 Billion Compound Annual Growth Rate 4.1% Regions Covered Asia-Pacific Key Topics Covered1. Introduction2. Research & Methodology3. Executive Summary4. Market Dynamics4.1 Growth Drivers4.2 Challenges5. Asia-Pacific Transdermal Skin Patches Market5.1 Historical Market Trends5.2 Market Forecast6. Asia-Pacific Transdermal Skin Patches Market Share Analysis6.1 By Type6.2 By Application6.3 By Distribution Channel6.4 By Countries7. Type7.1 Matrix7.2 Reservoir7.3 Drug-in-Adhesive7.4 Other Types8. Application8.1 Pain Relief8.2 Smoking Reduction and Cessation Aid8.3 Overactive Bladder8.4 Hormonal Therapy8.5 Others9. Distribution Channel9.1 Hospital Pharmacies9.2 Retail Pharmacies9.3 Online Pharmacies10. Countries10.1 China10.2 Japan10.3 India10.4 South Korea10.5 Thailand10.6 Malaysia10.7 Indonesia10.8 Australia10.9 New Zealand10.10 Rest of Asia-Pacific11. Porter's Five Forces Analysis11.1 Bargaining Power of Buyers11.2 Bargaining Power of Suppliers11.3 Degree of Rivalry11.4 Threat of New Entrants11.5 Threat of Substitutes12. SWOT Analysis12.1 Strength12.2 Weakness12.3 Opportunity12.4 Threat13. Key Players Analysis13.1 Teva Pharmaceutical Industries Ltd.13.2 3M Company13.3 Nitto Denko Corporation13.4 Johnson & Johnson13.5 Luye Pharma Group13.6 Bayer AG13.7 Novartis AG13.8 Beiersdorf AG13.9 Viatris Inc.13.10 Abbott Laboratories For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Asia-Pacific Transdermal Skin Patches Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Midea Numen AC: Awarded 2025 Red Dot for Cutting-Edge Technology and Designs Crafted for Southeast Asia Users
Midea Numen AC: Awarded 2025 Red Dot for Cutting-Edge Technology and Designs Crafted for Southeast Asia Users

Yahoo

time6 hours ago

  • Yahoo

Midea Numen AC: Awarded 2025 Red Dot for Cutting-Edge Technology and Designs Crafted for Southeast Asia Users

ESSEN, Germany, June 05, 2025--(BUSINESS WIRE)--Midea, the world's No.1 residential inverter air conditioner company, has reached a new milestone as its Midea Numen air conditioner won the prestigious German Red Dot Product Design Award 2025. Featuring an AI system and innovative structural design, Numen enhances energy efficiency and cooling experience, quickly gaining popularity in Malaysia and Thailand. Powered by the advanced AI ECOMASTER system, Numen balances energy saving with optimal comfort by adapting to environmental conditions and user preferences. With precise temperature control of ±0.3°C and verified 30% extra energy savings, it delivers smart, efficient cooling. Complementing this, Midea's cutting-edge inverter technology—backed by 27 years of development and over 3,300 patents—ensures high performance and reliability. Numen improves user experience with COOLFLASH technology that drops room temperature by 5°C within 10 minutes, even during extreme heat of up to 55°C. Its upgraded I-Clean frost cleaning removes more dust and bacteria, while the AIR MAGIC ion generator eliminates viruses efficiently. Designed for Southeast Asia's humid climate, it uses Prime Guard's six-layer protection including anti-corrosion copper tubes and UV-coated PCBs for durability. Thai and Malaysian customers are surprised by its cooling effectiveness, quiet operation, and reliable service. Numen's innovative PULL-DOWN STRUCTURE revolutionizes installation and maintenance by providing easy access to internal components, reducing PCB replacement to 74 seconds and motor replacement by 72%. For users, it simplifies cleaning with a taller air outlet and easily removable louvers, ensuring long-term efficiency and less downtime. With over 20 years of overseas market cultivation, Midea has established manufacturing and R&D centers in Southeast Asia, focusing on localized design and production. Committed to advancing inverter technology, Midea aims to deliver energy-efficient, user-friendly air conditioners that meet practical consumer needs in the region. Midea Official WebsiteMalaysia: View source version on Contacts MideaHarold Xuxuhao@ Sign in to access your portfolio

Medicines watchdog to open 'digital hub' in city
Medicines watchdog to open 'digital hub' in city

Yahoo

time6 hours ago

  • Yahoo

Medicines watchdog to open 'digital hub' in city

The UK's drug safety watchdog is to open a new "digital hub" in West Yorkshire. The site, to be located in Leeds city centre, would focus on digital delivery, software development and data science, according to the Medicines and Healthcare products Regulatory Agency (MHRA). The MHRA regulates new medicines, healthcare products and healthcare technologies for patients to use. Lawrence Tallon, MHRA chief executive, said opening the new site in the city was aimed at "strengthening our ability to collaborate with partners across the north of England". There had been a "huge growth" in healthcare technologies driven by changes in software and AI which were going to revolutionise the way the NHS worked, and the new Leeds hub would help regulate those technologies, Mr Tallon said. Leeds was chosen for the new hub as it was home to over 44,000 tech professionals and about 11,000 students studying tech-related subjects, according to the MHRA. The hub, in Wellington Place, would also serve as a base for the digital operations of NHS England, with increasing investment from major tech companies, an MHRA spokesperson said. About 30 permanent, highly-skilled roles would initially be recruited to work at the new centre in the city, they added. Wes Streeting, secretary of state for health and social care, said: "There is a global tech revolution in healthcare unfolding, and Yorkshire will help our country lead it. "This isn't just about creating new jobs across the region, it's also about bolstering a city that's already leading the way in digital health." Mr Tallon said that by establishing an MHRA digital hub in Leeds, "we're strengthening our ability to collaborate with partners across the north of England – bringing regulatory expertise closer to the people, organisations and innovations we serve". Meanwhile, he said Leeds was "buzzing, thriving, an exciting place". "We are really excited about create new jobs within our organisation right in the heart of Leeds," Mr Tallon added. Fiona Venner, Leeds City Council's executive member for equality, health and wellbeing, said the MHRA's announcement of the plan for a digital hub was "welcome". "Leeds is already a centre for digital health and innovation and this rapidly growing market contributes significantly to the economy," she said. "The hub will support the creation of jobs and provide career opportunities for local graduates and professionals." Listen to highlights from West Yorkshire on BBC Sounds, catch up with the latest episode of Look North. Indian tech firm to create 1,000 jobs in city Sky to create up to 400 jobs in city Medicines and Healthcare products Regulatory Agency NHS England

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store